Dr. Golub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Broad Institute
7 Cambridge Center
Cambridge, MA 02142Phone+1 617-714-7050- Is this information wrong?
Education & Training
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1989 - 1991
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989
Certifications & Licensure
- MA State Medical License 1994 - 2024
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
- Investigator Howard Hughes Medical Institute
Publications & Presentations
Journal Articles
- Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory CircuitryWilliam C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
- Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug ResponseTodd R Golub, Rameen Beroukhim, Pratiti Bandopadhayay, Nature
- Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROSStuart L Schreiber, Todd R Golub, Nature
- Join now to see all
Press Mentions
- René Salazar Joins Broad Institute as Chief Equity OfficerOctober 14th, 2021
- 40th Anniversary Recollections & PredictionsOctober 4th, 2021
- Novo Nordisk Foundation, Harvard, MIT Launch Research Center with Focus on DiabetesSeptember 15th, 2021
- Join now to see all
Grant Support
- Broad Institute Center For Cancer Systems BiologyNational Cancer Institute2010–2012
- Large Scale Gene Expression Analysis Of Cellular StatesNational Human Genome Research Institute2010–2011
- Discovery Pipeline (2 Of 4)National Cancer Institute2009–2011
- Molecular Signatures Of Melanoma: Predicting Response To Therapy &TargetingNational Cancer Institute2008–2011
- Genomics And BioinformaticsNational Cancer Institute2007–2011
- Connectivity MAP 100KNational Human Genome Research Institute2009–2010
- Genomics And BioinformaticsNational Cancer Institute2006–2010
- Anti-All Small Molecular Discovery VIA Chemical GenomicsNational Cancer Institute2006–2010
- Discovery Of Inhibitors Of Anti-Apoptotic Protein A1National Institute On Drug Abuse2009
- Signatures Of Kinase Activation In CancerNational Cancer Institute2004–2009
- Discovery Pipeline (2 Of 4)National Cancer Institute2007–2008
- Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2005–2007
- Genomic Expression Analysis Of Tumors After Radical ProstatectomyNational Cancer Institute2002
- Core--GenomicsNational Cancer Institute2002
- Core--Dna Microarray And BioinformaticsNational Cancer Institute2001–2002
- Genomic Predictor Of Acute Lymphocytic Leukemia BiologyNational Cancer Institute2000–2002
- Characterization Of TEL, A New Leukemogenic ETS ProteinNational Cancer Institute1997–2001
- TEL Gene And LeukemiasNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: